Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C

Journal of Virology

Volumn 78, Issue 17, 2004, Pages 8971-8982

  De Rozières, Sohela ^a   Mathiason, Candace K ^b   Rolston, Matthew R ^a   Chatterji, Udayan ^a   Hoover, Edward A ^b   Elder, John H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; CAT; CAT DISEASE; CELL LINE; CELL STRAIN CRFK; CLADISTICS; CLONE; CLONE FELINE IMMUNODEFICIENCY VIRUS C36; CLONE FELINE IMMUNODEFICIENCY VIRUS PETALUMA; CLONE FELINE IMMUNODEFICIENCY VIRUS PPR; DIARRHEA; FELINE IMMUNODEFICIENCY VIRUS; FELINE IMMUNODEFICIENCY VIRUS CABCPADY00C; FELINE IMMUNODEFICIENCY VIRUS CLADE C; FELINE IMMUNODEFICIENCY VIRUS SUBGROUP A CLONE; FEVER; GENBANK; GENETIC VARIABILITY; IMMUNE DEFICIENCY; LYMPHOCYTE DEPLETION; LYMPHOID CELL LINE; MOLECULAR CLONING; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYELONEPHRITIS; RETROVIRUS INFECTION; SEQUENCE HOMOLOGY; STOMATITIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TONSILLITIS; VIRUS CELL INTERACTION; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS TYPING; VIRUS VIRULENCE; WEIGHT REDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CATS; CD4-CD8 RATIO; CELLS, CULTURED; CLONING, MOLECULAR; DATABASES, GENETIC; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE ORDER; GENE PRODUCTS, ENV; IMMUNODEFICIENCY VIRUS, FELINE; LYMPHOID TISSUE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RNA; RNA, VIRAL; T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES; TRANSFECTION; VARIATION (GENETICS);

EID: 4143055904     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.17.8971-8982.2004     Document Type: Article

References (59)

1. Bachmann, M. H., C. Mathiason-Dubard, G. H. Learn, A, G. Rodrigo, D. L. Sodora, P. Mazzetti, E. A. Hoover, and J. I. Mullins. 1997. Genetic diversity evolutionary rates among envelope sequence clades. J. Virol. 71:4241-4253.
2. Bendinelli, M., M. Pistello, D. Del Mauro, G. Cammarota, F. Maggi, A. Leonildi, S. Giannecchini, C. Bergamini, and D. Matteucci. 2001. During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. J. Virol. 75:4584-4593.
3. Cammarota, G., D. Matteucci, M. Pistello, E. Nicoletti, S. Giannecchini, and M. Bendinelli. 1996. Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein. AIDS Res. Hum. Retrovir. 12:173-175.
4. Chatterji, U., A. de Parseval, and J. H. Elder. 2002. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators. J. Virol. 76:9624-9634.
5. + T lymphocytes suppresses FIV replication. J. Virol. 74:676-683.
6. Coull, J. J., F. Romerio, J. M. Sun, J. L. Volker, K. M. Galvin, J. R. Davie, V. Shi, U. Hansen, and D. M. Margolis. 2000. The human factors YYI and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase I. J. Virol. 74:6790-6799.
7. Crawrford, P. C., G. P. Papadi, J. K. Levy, N. A. Benson, A. Mergia, and C. M. Johnson. 2001. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus. J. Infect. Dis. 184:671-681.
8. de Monte, M., H. Nonnenmacher, N. Brignon, M. Ullmann, and J. P. Martin. 2002. A multivariate statistical analysis to follow the course of disease after infection of cats with different strains of the feline immunodeficiency virus (FIV). J. Virol. Methods 103:157-170.
9. de Parseval, A., and J. H. Elder. 1999. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J. Virol. 73:608-617.
10. Diehl, L. J., C. K. Mathiason-DuBard, L. L. O'Neil, and E. A. Hoover. 1995. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J. Virol. 69:2328-2332.
11. Diehl, L. J., C. K. Mathiason-Dubard, L. L. O'Neil, L. A. Obert, and E. A. Hoover. 1995. Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J. Virol. 69:6149-6157.
12. English, R. V., P. Nelson, C. M. Johnson, M. Nasisse, W. A. Tompkins, and M. B. Tompkins. 1994. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170:543-552.
13. Flynn, J. N., C. A. Cannon, D. Sloan, J. C. Neil, and O. Jarrett. 1999. Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes. Immunology 96:220-229.
14. Hohdatsu, T., T. Sasagawa, A. Yamazaki, K. Motokawa, H. Kusuhara, T. Kaneshima, and H. Koyama. 2002. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro. Arch. Virol. 147:1517-1529.
15. Hosie, M. J., B. J. Willett, D. Klein, T. H. Dunsford, C. Cannon, M. Shimojima, J. C. Neil, and O. Jarrett. 2002. Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J. Virol. 76:6062-6072.
16. Inoshima, Y., M. Kohmoto, Y. Ikeda, H. Yamada, Y. Kawaguchi, K. Tomonaga, T. Miyazawa, C. Kai, T. Umemura, and T. Mikami. 1996. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70:8518-8526.
17. Ishida, T., T. Washizu, K. Toriyabe, S. Motoyoshi, I. Tomoda, and N. C. Pedersen. 1989. Feline immunodeficiency virus infection in cats of Japan. J. Am. Vet. Med. Assoc. 194:221-225.
18. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
19. Lerner, D. L., and J. H. Elder. 2000. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells. J. Virol. 74:1854-1863.
20. Lerner, D. L., C. K. Grant, A. de Parseval, and J. H. Elder. 1998. FIV infection of IL-2-dependent and -independent feline lymphocyte lines: host cells range distinctions and specific cytokine upregulation. Vet. Immunol. Immunopathol. 65:277-297.
21. Lin, Y. S., and M. R. Green. 1988. Interaction of a common cellular transcription factor, ATF, with regulatory elements in both E1a- and cyclic AMP-inducible promoters. Proc. Natl. Acad. Sci. USA 85:3396-3400.
22. Malim, M. H., R. Fenrick, D. W. Ballard, J. Hauber, E. Bohnlein, and B. R. Cullen. 1989. Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. J. Virol, 63:3213-3219.
23. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
24. Mancuso, V. A., T. J. Hope, L. Zhu, D. Derse, T. Phillips, and T. G. Parslow, 1994. Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J. Virol. 68:1998-2001.
25. Mangeat, B., P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
26. Mariani, R., D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N. R. Landau. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114:21-31.
27. Miyazawa, T., M. Fukasawa, A. Hasegawa, N. Maki, K. Ikuta, E. Takahashi, M. Hayami, and T. Mikami. 1991. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J. Virol. 65:1572-1577.
28. Myers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.M.
29. Nazarenko, I., R. Pires, B. Lowe, M. Obaidy, and A. Rashtchian. 2002. Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes. Nucleic Acids Res. 30:2089-2195.
30. Olmsted, R. A., A. K. Barnes, J. K. Yamamoto, V. M. Hirsch, R. H. Purcell, and P. R. Johnson. 1989. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:2448-2452.
31. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
32. Pedersen, N. C., C. M. Leutenegger, J. Woo, and J. Higgins. 2001. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats. Vet. Immunol. Immunopathol. 79:53-67.
33. Pedersen, N. C., J. K. Yamamoto, T. Ishida, and H. Hansen. 1989. Feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 21:111-129.
34. Phillips, T. R., C. Lament, D. A. Konings, B. L. Shacklett, C. A. Hamson, P. A. Luciw, and J. H. Elder. 1992. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66:5464-5471.
35. Phillips, T. R., R. L. Talbott, C. Lamont, S. Muir, K. Lovelace, and J. H. Elder. 1990. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:4605-4613.
36. Poeschla, E. M., and D. J. Looney. 1998. CXCR4 is required by a nonprimate lentivirus: helerologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J. Virol 72:6858-6866.
37. Rigby, M. A., E. C. Holmes, M. Pistello, A. Mackay, A. J. Brown, and J. C. Neil. 1993. Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J. Gen. Virol. 74(Pt 3):425-436.
38. Ryan, G., D. Klein, E. Knapp, M. J. Hosie, T. Grimes, M. J. Mabruk, O. Jarrett, and J. J. Callanan. 2003. Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. J. Virol. 77:7477-7485.
39. Shacklett, B. L., and P. A. Luciw. 1994. Analysis of the vif gene of feline immunodeficiency virus. Virology 204:860-867.
40. Siebelink, K. H., W. Huisman, J. A. Karlas, G. F. Rimmelzwaan, M. L. Bosch, and A. D. Osterhaus. 1995. Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J. Virol. 69:5124-5127.
41. Siebelink, K. H., J. A. Karlas, G. F. Rimmelzwaan, A. D. Osterhaus, and M. L. Bosch. 1995. A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet. Immunol. Immunopathol. 46:61-69.
42. Sodora, D. L., E. G. Shpaer, B. E. Kitchell, S. W. Dow, E. A. Hoover, and J. I. Mullins. 1994. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 68:2230-2238.
43. Sova, P., M. van Ranst, P. Gupta, R. Balachandran, W. Chao, S. Itescu, G. McKinley, and D. J. Volsky. 1995. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J. Virol. 69:2557-2564.
44. Sparger, E. E., A. M. Beebe, N. Dua, S. Himathongkam, J. H. Elder, M. Torten, and J. Higgins. 1994. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. Virology 205:546-553.
45. Sparger, E. E., B. L. Shacklett, L. Renshaw-Gegg, P. A. Barry, N. C. Pedersen, J. H. Elder, and P. A. Luciw. 1992. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology 187:165-177.
46. Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
47. Tomonaga, K., T. Miyazawa, J. Sakuragi, T. Mori, A. Adachi, and T. Mikami. 1993. The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes. J. Virol. 67:5889-5895.
48. Tomonaga, K., J. Norimine, Y. S. Shin, M. Fukasawa, T. Miyazawa, A. Adachi, T. Toyosaki, Y. Kawaguchi, C. Kai, and T. Mikami. 1992. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66:6181-6185.
49. Vahlenkamp, T. W., A. de Ronde, N. N. Schuurman, A. L. van Vliet, J. van Drunen, M. C. Horzinek, and H. F. Egberink. 1999. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J. Gen. Virol. 80(Pt 10):2639-2646.
50. Vahlenkamp, T. W., E. J. Verschoor, N. N. Schuurman, A. L. van Vliet, M. C. Horzinek, H. F. Egberink, and A. de Ronde. 1997. A single amino acid deficiency virus alters cellular tropism. J. Virol. 71:7132-7135.
51. Verschoor, E. J., L. A. Boven, H. Blaak, A. L. van Vliet, M. C. Horzinek, and A. de Ronde. 1995. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells, J. Virol. 69:4752-4757.
52. Waters, A. K., A. P. De Parseval, D. L. Lerner, J. C. Neil, F. J. Thompson, and J. H. Elder. 1996. Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology 215:10-16.
53. Wieland, U., J. Hartmann, H. Suhr, B. Salzberger, H. J. Eggers, and J. E. Kuhn. 1994. In vivo genetic variability of the HIV-1 vif gene. Virology 203:43-51.
54. Willett, B. J., L. Picard, M. J. Hosie, J. D. Turner, K. Adema, and P. R. Clapham. 1997. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:6407-6415.
55. Yamamoto, J. K., H. Hansen, E. W. Ho, T. Y. Morishita, T. Okuda, T. R. Sawa, R. M. Nakamura, and N. C. Pedersen. 1989. Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J. Am. Vet. Med. Assoc. 194:213-220.
56. Yamamoto, J. K., E. Sparger, E. W. Ho, P. R. Andersen, T. P. O'Connor, C. P. Mandell, L. Lowenstine, R. Munn, and N. C. Pedersen. 1988. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49:1246-1258.
57. Yang, J. S., R. V. English, J. W. Ritchey, M. G. Davidson, T. Wasmoen, J. K. Levy, D. H. Gebhard, M. B. Tompkins, and W. A. Tompkins. 1996. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J. Virol. 70:3011-3017.
58. Yang, X., J. Goncalves, and D. Gabuzda. 1996. Phosphorylation of Vif and its role in HIV-1 replication. J. Biol. Chem. 271:10121-10129.
59. Zhang, H., B. Yang, R. J. Pomerantz, C. Zhang, S. C. Arunachalam, and L. Gao. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.